The Official MicroCap News Source
Watchlist News
Please Login or Register to view News Stories

Cyclacel Pharmaceuticals - Clinical-stage Biopharmaceutical Company Provides Update on Clinical Development and Growth Drivers for 2019

SNNLive spoke with Spiro Rombotis, President and CEO of Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC) at the BIO CEO & Investor Conference 2019

Share With

Tuesday, March 26, 2019

   

© 2019 Stock News Now